1 / 1
Pharmaceutical
Fem 7 Combi
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
faza I: 50 mcg/24 h (1,5 mg); faza II: 50 mcg/24 h (1,5 mg) + 10 mcg/24 h (1,5 mg)
Strength
faza I: 50 mcg/24 h (1,5 mg); faza II: 50 mcg/24 h (1,5 mg) + 10 mcg/24 h (1,5 mg)
Pack Size
-
Form
System transdermalny
Source
Rejestry E-zdrowia
